Organization
Hôpital Européen Georges-Pompidou, Paris
5 abstracts
Abstract
Consistent data about the predictive factors of the success of interval debulking surgery (CC0-IDS) in patients with advanced ovarian cancers in two large independent datasets.Org: Centre Hospitalier Lyon Sud, Pierre-Benite, GINECO, Paris, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Roma, Italy, EA3738 Ciblage Thérapeutique en Oncologie, Oullins, UCBL EA3738 CICLY, Oullins,
Abstract
Transcriptomic signatures of MSI-high metastatic colorectal cancer to predict efficacy of immune checkpoint inhibitors.Org: Institut du Cancer Paris CARPEM, APHP-INSERM U1149 Universite Paris Diderot, Digestive Oncology Department, APHP.Centre - Université Paris Cité, Hôpital Européeen G. Pompidou,
Abstract
Predictive models of recurrence from transcriptomic signatures of the tumor microenvironment and cell cycle in stage III colon cancer from PETACC-8 and IDEA France trials.Org: Institut du Cancer Paris CARPEM, APHP-INSERM U1149 Universite Paris Diderot, APHP.Centre - Université Paris Cité, Université Paris Cité, Hôpital Européeen G. Pompidou,
Abstract
Effect of national multidisciplinary tumor boards on diagnostic stratification and therapeutic management in cancers of unknown primary.Org: Institut Curie, Saint Cloud, France, Gustave Roussy Département d'Organisation du Parcours Patient, AP-HP at Saint-Louis Hospital, Hôpital Cochin Port-Royal, Centre Léon Bérard,
Abstract
Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: An AGEO European Cohort.Org: Hôpital Européen Georges-Pompidou, Paris, Department of Medicine III and Comprehensive Cancer Center, University Hospital, LMU Munich, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland, University Hospital 12 de Octubre, LMU Munich,